Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer

Kelly, R; Jensen, A; Karunaratna, N; Wong, S; Shapiro, J; Weickhardt, A; Parente, P; Azad, AA; Uccellini, A; Torres, J; Parnis, F; Goh, J; Kwan, EM; Brown, S; Steer, C; Warren, M; Gibbs, P; Tran, B; Anton, A

Author(s): Kelly, R; Jensen, A; Karunaratna, N; Wong, S; Shapiro, J; Weickhardt, A; Parente, P; Azad, AA; Uccellini, A; Torres, J; Parnis, F; Goh, J; Kwan, EM; Brown, S; Steer, C; Warren, M; Gibbs, P; Tran, B; Anton, A;
Details: Publication Year 2023-02,Volume 131,Issue #2,Page 179-182
Journal Title: BJU International
Publication Type: Research article
Publisher: Wiley
Keywords: Male; Humans; Positron Emission Tomography Computed Tomography/methods; *Prostatic Neoplasms, Castration-Resistant/diagnostic imaging/drug; therapy/pathology; Prostate/pathology; *Prostatic Neoplasms; Prostate-Specific Antigen
Department(s): Medical Oncology
PubMed ID: 36371671
Publisher's Version: https://doi.org/10.1111/bju.15930
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2023-05-30 07:27:53

Last Modified: 2023-05-30 07:28:52